Zealand Pharma A/S | ZEAL - Net Income


Zealand Pharma A/S reported -379.12M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.01M 153K Mar/2026
Avita Medical AUD -11.62M 1.7M Dec/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Ionis Pharmaceuticals USD -114.65M 21.65M Jun/2026
IQVIA Holdings USD 256M 18M Jun/2026
Moderna USD -1.34B 517M Mar/2026
Organon & Co USD 146M 351M Mar/2026
Revvity USD 40.72M 57.65M Mar/2026
Tectonic Therapeutic USD -25.24M 6.02M Mar/2026
Tilray USD -44.93M 44.61M Sep/2025
Viatris USD 176.4M 516.5M Mar/2026
Xeris Pharmaceuticals USD 2.23M 8.85M Mar/2026
Zealand Pharma A/S -379.12M 25.12M Dec/2025